Feds ease heroin controls to tackle opioid epidemic
OTTAWA — Access to treatment for opioid addiction is about to get easier as the federal government promises changes to drug laws that would do away with some of the obstacles preventing doctors from offering prescription heroin and methadone.
Forthcoming legal changes will allow patients to access, when appropriate, prescribed heroin outside of a hospital setting, such as addiction clinics, making it easier for them to balance their treatment with daily responsibilities.
The government is also making methadone more accessible, allowing health-care practitioners to prescribe and administer it without needing to apply for an exemption from federal law.
Health Minister Ginette Petitpas Taylor said Monday that removing barriers to treatment is crucial to combat what her department describes as a national public health crisis that continues to devastate families and communities.
“We know way too many parents, sisters, brothers, daughters, sons or loved ones who have died because of opioids,” Petitpas Taylor said. “I believe we can turn the tide on this crisis. And we can do it together.”
Health Canada estimates about 2,900 people died in 2016 as a result of the crisis; estimates to be released Tuesday suggest the epidemic claimed more than 4,000 lives last year.
The Controlled Drug and Substances Act currently requires that physicians apply for an exemption from federal law to be allowed to prescribe, administer, sell or provide methadone.
The government’s announced changes will mean doctors no longer require an exemption, something Petitpas Taylor called a barrier that discourages the treatment from being offered.
Nurse practitioners who work in one of the six provinces that already allows them to prescribe methadone will also no longer be required to apply for an exemption — those include Nova Scotia, New Brunswick, Newfoundland and Labrador, Manitoba, Alberta and British Columbia.
The new regulations are expected to come into effect in May and stem from a guideline released earlier this month by the Canadian Research Initiative in Substances Misuse.